Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/28/2024 | $90.00 | Buy | Jefferies |
8/7/2024 | $73.00 → $75.00 | Underperform → Neutral | BofA Securities |
6/24/2024 | $72.00 | Neutral | Goldman |
4/1/2024 | $87.00 → $80.00 | Positive → Neutral | Susquehanna |
3/19/2024 | $80.00 | Neutral | Guggenheim |
1/30/2024 | $82.00 | Neutral | Mizuho |
1/5/2024 | $67.00 | Hold → Sell | Societe Generale |
1/4/2024 | Underperform → Peer Perform | Wolfe Research |
Revenue of $5.0 billion, increased 3.0% year-over-year or 2.7% in constant currency1, the high end of our guidance rangesOperating margin of 14.6%, sequentially flat and increased 60 basis points year-over-year; year-to-date operating margin of 14.6%, increased 110 basis points year-over-yearAdjusted Operating Margin1 of 15.3%, increased 10 basis points sequentially and decreased 20 basis points year-over-year; year-to-date Adjusted Operating Margin of 15.2%, increased 40 basis points year-over-yearTrailing 12-month bookings of $26.2 billion; book-to-bill of 1.3xStrong growth in Health Sciences, up 7.8% year-over-year or 7.6% in constant currency, and return to growth in Financial Services,
Launched about one year ago, Cognizant created Synapse as a global program to equip individuals with the technology skills they need to be part of the workforce of the future. TEANECK, N.J., Oct. 29, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) today announced it has reached more than 275,000 people via its global skilling initiative, Synapse, which launched one year ago in October, 2023. This milestone shows Cognizant is more than a quarter of the way toward reaching the program's goal to advance technology job training for one million people worldwide by the end of 2026. The
Utilizing Cognizant's top-tier managed services frameworks and tools, the partnership aims to enhance Alnylam's automation and reduce operational efforts TEANECK, N.J., Oct. 29, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) announced today a new agreement with Alnylam Pharmaceuticals, Inc., a leading biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics. Cognizant will serve as an integral IT Managed Services provider for Alnylam. This collaboration aims to scale Alnylam's IT operations and accelerate its capabilities in delivering transformative medicines.
In the last three months, 9 analysts have published ratings on Cognizant Tech Solns (NASDAQ:CTSH), offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 8 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 1 0 0 3M Ago 0 1 5 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $77.89, a high estimate of $85.00, and a low estimate of $72.00. Highlightin
Barclays analyst Ramsey El-Assal maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Equal-Weight and raises the price target from $75 to $80.
Cognizant (NASDAQ:CTSH) and Whitbread have expanded their digital transformation relationship which will see the professional services provider support the hospitality company's ongoing digital transformation with product design, product management and engineering as Whitbread expands its operations in the UK and Germany.
Jefferies resumed coverage of Cognizant Tech with a rating of Buy and set a new price target of $90.00
BofA Securities upgraded Cognizant Tech from Underperform to Neutral and set a new price target of $75.00 from $73.00 previously
Goldman initiated coverage of Cognizant Tech with a rating of Neutral and set a new price target of $72.00
10-Q - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Filer)
8-K - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Filer)
8-K/A - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Filer)
4 - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Issuer)
4 - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Issuer)
4/A - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Issuer)
Industry veteran brings 30 years of service, operations and digital experience to the role TEANECK, N.J., Aug. 21, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) today announced the appointment of Rajesh Varrier as Global Head of Operations, effective September 2, 2024. Additionally, he will be appointed as Chairman & Managing Director, India, assuming the role October 1, 2024, as Rajesh Nambiar leaves Cognizant to become president of NASSCOM. Varrier will be an Executive Vice President of Cognizant, reporting to Ravi Kumar S, Cognizant's Chief Executive Officer. Varrier will be based in Bangalore, India.
Silvent brings significant experience in human resources, talent management, public policy and government affairs TEANECK, N.J., July 11, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) today announced the appointment of Karima Silvent to its Board of Directors (the "Board") as an independent director, effective immediately. In connection with Ms. Silvent's appointment, Cognizant's Board has expanded to 13 members, 12 of whom are independent. Ms. Silvent currently serves as Group Chief Human Resources Officer and a member of the Management Committee of AXA, a French multinationa
Congruent Solutions, a leading provider of Software-as-a-Service (SaaS) and outsourced plan administration services to the retirement industry in the U.S., today announced the appointment of Mahesh Natarajan as its Chief Revenue Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424370676/en/Mahesh Natarajan, CRO, Congruent Solutions (Photo: Business Wire) Natarajan is an acknowledged techno-business leader in the insurance and retirement industry, having spent over 25 years with Cognizant (NASDAQ:CTSH), serving clients in the U.S. In this newly created role, Natarajan will be responsible for strengthening strategic rela
SC 13G/A - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Subject)
SC 13G - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Subject)
SC 13G/A - COGNIZANT TECHNOLOGY SOLUTIONS CORP (0001058290) (Subject)
Revenue of $5.0 billion, increased 3.0% year-over-year or 2.7% in constant currency1, the high end of our guidance rangesOperating margin of 14.6%, sequentially flat and increased 60 basis points year-over-year; year-to-date operating margin of 14.6%, increased 110 basis points year-over-yearAdjusted Operating Margin1 of 15.3%, increased 10 basis points sequentially and decreased 20 basis points year-over-year; year-to-date Adjusted Operating Margin of 15.2%, increased 40 basis points year-over-yearTrailing 12-month bookings of $26.2 billion; book-to-bill of 1.3xStrong growth in Health Sciences, up 7.8% year-over-year or 7.6% in constant currency, and return to growth in Financial Services,
TEANECK, N.J., Oct. 9, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH), a leading provider of information technology, consulting, and business process services, will announce results for the third quarter of 2024 on Wednesday, October 30, 2024 after market close. Following the release, Cognizant management will conduct a conference call at 5:00 p.m. (Eastern) to discuss operating performance for the quarter. To participate in the conference call, domestic callers can dial 877-810-9510 and international callers can dial 201-493-6778 and provide the following conference passcode: C
TEANECK, N.J., Aug. 27, 2024 /PRNewswire/ -- Cognizant (NASDAQ:CTSH) today announced it completed the acquisition of Belcan for approximately $1.3 billion in cash and stock. Belcan is a leading global supplier of Engineering Research & Development (ER&D) services for the commercial aerospace, defense, space, marine and industrial verticals. First announced in June 2024, the strategic acquisition strengthens Cognizant's engineering capabilities, builds on its leadership in the Internet of Things (IoT) and Digital Engineering practice areas, and increases its presence in the h